75.08EUR+0.11%Mkt Cap: 97.68B $P/E: 18.961d ago
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelit…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Avg
P/B
Cheaper
Div Yield
Lower
1M Perf
Higher
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
PHOO
Photocure ASA—
ROSE
DocMorris AG—
FLXN
Horizon Flexible Income ETF—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap97.68B $
Enterprise Value114.37B $
Revenue (TTM)51.47B $
Gross Profit36.59B $
Net Income (TTM)8.49B $
Revenue/Share42.43 USD
Last Price75.08 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees74.8K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000120578
Valuation
P/E (Trailing)18.96
P/E (Forward)8.33
PEG3.77
EV/EBITDA8.20
EV/Revenue2.22
P/S1.90
P/B1.24
EPS (TTM)3.96
EPS (Forward)9.01
52W Range
71.2519% of range91.15
52W High91.15 EUR
52W Low71.25 EUR
Profitability
Gross Margin72.07%
Oper. Margin20.00%
EBITDA Margin27.09%
Profit Margin16.72%
ROE10.95%
ROA6.16%
Growth
Revenue Growth6.00%
Earnings Growth-11.70%
Cash Flow & Leverage
Operating CF11.68B $
CapEx (TTM)3.85B $
FCF Margin35.21%
FCF Yield18.55%
Net Debt15.74B $
Net Debt/EBITDA1.13
Balance Sheet
Debt/Equity0.28
Current Ratio1.00
Quick Ratio0.20
Book Value/Sh60.46 EUR
Cash/Share4.604 EUR
Dividends
Fwd Div Rate4.120 EUR
Trail. Div Rate0.0000 EUR
Div. Yield5.46%
5Y Avg Yield3.97%
Payout Ratio98.99%
Ex-Div DateMay 5, 2026
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)96.70 EUR
Upside (mean)+28.8%
Target Range82.00 EUR – 112.00 EUR
€82.00+28.8% to mean€112.00
# Analysts23
Ownership
Shares Out.1.20B
Float1.09B
Insiders10.26%
Institutions42.67%
Technical
SMA 5076.00 (-1.2%)
SMA 20080.69 (-7.0%)
Beta0.28
S&P 52W Chg20.05%
Avg Vol (30d)1.79M
Avg Vol (10d)3.27M
Technical Indicators
RSI (14)49.7
MACD-0.5732
MACD Signal-0.5991
MACD Hist.+0.0259
BB Upper78.32 EUR
BB Middle75.06 EUR
BB Lower71.80 EUR
BB Width8.68%
ATR (14)1.819 EUR
Vol Ratio (20d)1.92x